CASTALDI DAVID L 4
4 · NABI BIOPHARMACEUTICALS · Filed May 17, 2005
Insider Transaction Report
Form 4
CASTALDI DAVID L
Director
Transactions
- Award
Stock Option (right to buy)
2005-05-13+12,000→ 12,000 totalExercise: $11.26From: 2005-11-13Exp: 2015-05-13→ Common Stock (12,000 underlying)